These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 20636875)
1. Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions. Wu Z; Tucker IG; Razzak M; McSporran K; Medlicott NJ J Pharm Pharmacol; 2010 Jul; 62(7):873-82. PubMed ID: 20636875 [TBL] [Abstract][Full Text] [Related]
2. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep. Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175 [TBL] [Abstract][Full Text] [Related]
3. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310 [TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics. Wu Z; Razzak M; Tucker IG; Medlicott NJ J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques. Kalaiselvan R; Mohanta GP; Madhusudan S; Manna PK; Manavalan R Pharmazie; 2007 Aug; 62(8):604-7. PubMed ID: 17867556 [TBL] [Abstract][Full Text] [Related]
6. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use. Holvoet C; Heyden YV; Plaizier-Vercammen J Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403 [TBL] [Abstract][Full Text] [Related]
7. Complexation and solubility behavior of albendazole with some cyclodextrins. Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560 [TBL] [Abstract][Full Text] [Related]
8. Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium. Jansen T; Xhonneux B; Mesens J; Borgers M Lens Eye Toxic Res; 1990; 7(3-4):459-68. PubMed ID: 2100172 [TBL] [Abstract][Full Text] [Related]
9. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin. Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071 [TBL] [Abstract][Full Text] [Related]
10. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits. Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. Piette M; Evrard B; Frankenne F; Chiap P; Bertholet P; Castagne D; Foidart JM; Delattre L; Piel G Eur J Pharm Sci; 2006 Jun; 28(3):189-95. PubMed ID: 16520026 [TBL] [Abstract][Full Text] [Related]
12. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins]. Kopecký F; Kopecká B; Kaclík P Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery. Figueiras A; Hombach J; Veiga F; Bernkop-Schnürch A Eur J Pharm Biopharm; 2009 Feb; 71(2):339-45. PubMed ID: 18796330 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep. Formentini EA; Mestorino N; Errecalde JO Vet Res Commun; 2005 Oct; 29(7):595-608. PubMed ID: 16142607 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Liu J; Qiu L; Gao J; Jin Y Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034 [TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. Sintov AC; Levy HV; Botner S J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120 [TBL] [Abstract][Full Text] [Related]
17. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents. Holvoet C; Vander Heyden Y; Plaizier-Vercammen J Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191 [TBL] [Abstract][Full Text] [Related]
18. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin. Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028 [TBL] [Abstract][Full Text] [Related]
19. [Dissolution and signs of supersaturation of nimodipine in aqueous solutions of the cyclodextrins, alpha-CD, HP-alpha-CD, M-beta-CD and HP-gamma-CD]. Kopecký F; Kopecká B; Kaclík P Ceska Slov Farm; 1999 Nov; 48(6):287-90. PubMed ID: 10748748 [TBL] [Abstract][Full Text] [Related]
20. [Preparation of albendazole polybutycyanocrylate nanoparticles and study on its pharmaceutical properties and tissue distribution]. Zhang XN; Zhang Q; Wen H; Wang GQ; Sun DJ Yao Xue Xue Bao; 2003 Jun; 38(6):462-6. PubMed ID: 14513810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]